BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 26003897)

  • 1. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: "NASHOST" prospective observational trial.
    Praveen Raj P; Gomes RM; Kumar S; Senthilnathan P; Karthikeyan P; Shankar A; Palanivelu C
    Surg Obes Relat Dis; 2015; 11(6):1315-22. PubMed ID: 26003897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study.
    Froylich D; Corcelles R; Daigle C; Boules M; Brethauer S; Schauer P
    Surg Obes Relat Dis; 2016 Jan; 12(1):127-31. PubMed ID: 26077701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
    Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
    Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.
    Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C
    Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score).
    von Schönfels W; Beckmann JH; Ahrens M; Hendricks A; Röcken C; Szymczak S; Hampe J; Schafmayer C
    Surg Obes Relat Dis; 2018 Oct; 14(10):1607-1616. PubMed ID: 30146425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease.
    Clark JM; Alkhuraishi AR; Solga SF; Alli P; Diehl AM; Magnuson TH
    Obes Res; 2005 Jul; 13(7):1180-6. PubMed ID: 16076987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
    Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
    Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver Function in Patients With Nonalcoholic Fatty Liver Disease Randomized to Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy: A Secondary Analysis of a Randomized Clinical Trial.
    Kalinowski P; Paluszkiewicz R; Ziarkiewicz-Wróblewska B; Wróblewski T; Remiszewski P; Grodzicki M; Krawczyk M
    Ann Surg; 2017 Nov; 266(5):738-745. PubMed ID: 28767558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years.
    Furuya CK; de Oliveira CP; de Mello ES; Faintuch J; Raskovski A; Matsuda M; Vezozzo DC; Halpern A; Garrido AB; Alves VA; Carrilho FJ
    J Gastroenterol Hepatol; 2007 Apr; 22(4):510-4. PubMed ID: 17376042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of nonalcoholic fatty liver disease after bariatric surgery in morbidly obese Chinese patients.
    Tai CM; Huang CK; Hwang JC; Chiang H; Chang CY; Lee CT; Yu ML; Lin JT
    Obes Surg; 2012 Jul; 22(7):1016-21. PubMed ID: 22161114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study.
    Nickel F; Tapking C; Benner L; Sollors J; Billeter AT; Kenngott HG; Bokhary L; Schmid M; von Frankenberg M; Fischer L; Mueller S; Müller-Stich BP
    Obes Surg; 2018 May; 28(5):1342-1350. PubMed ID: 29119336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
    Weiner RA
    Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study.
    Caiazzo R; Lassailly G; Leteurtre E; Baud G; Verkindt H; Raverdy V; Buob D; Pigeyre M; Mathurin P; Pattou F
    Ann Surg; 2014 Nov; 260(5):893-8; discussion 898-9. PubMed ID: 25379859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass.
    Larson SP; Bowers SP; Palekar NA; Ward JA; Pulcini JP; Harrison SA
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1329-32. PubMed ID: 17702661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis.
    Fakhry TK; Mhaskar R; Schwitalla T; Muradova E; Gonzalvo JP; Murr MM
    Surg Obes Relat Dis; 2019 Mar; 15(3):502-511. PubMed ID: 30683512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
    Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
    Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Shouhed D; Steggerda J; Burch M; Noureddin M
    Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):797-811. PubMed ID: 28712339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome.
    Qureshi K; Abrams GA
    Clin Obes; 2016 Apr; 6(2):117-23. PubMed ID: 26856683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BYPASS VS. SLEEVE AND ITS EFFECTS IN NON-ALCOHOLIC FATTY LIVER DISEASE: WHAT IS THE BEST TECHNIQUE?
    Goldoni MB; Fontes PRO; GuimarÃes MM; Diedrich-Neto JA; Nogueira T; Teixeira UF; Giacomazzi CB; Kiss G; Pioner SR; Rodrigues PD
    Arq Bras Cir Dig; 2021; 33(3):e1549. PubMed ID: 33470379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome.
    Mattar SG; Velcu LM; Rabinovitz M; Demetris AJ; Krasinskas AM; Barinas-Mitchell E; Eid GM; Ramanathan R; Taylor DS; Schauer PR
    Ann Surg; 2005 Oct; 242(4):610-7; discussion 618-20. PubMed ID: 16192822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.